NYSEMKT: AEONAeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?
Insider buying vs selling
Have Aeon Biopharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jost Fischer | Director | 2025-05-21 | 60,000 | $0.49 | $29.22kBuy |
| Jost Fischer | Director | 2025-05-20 | 60,000 | $0.51 | $30.36kBuy |
| Jost Fischer | Director | 2025-05-19 | 50,000 | $0.50 | $24.95kBuy |
AEON insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AEON insiders and whales buy or sell their stock.
AEON Shareholders
What type of owners hold Aeon Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Priveterra Sponsor LLC | 117.32% | 13,889,163 | $11.42M | Insider |
| Daewoong Co Ltd | 55.56% | 6,577,604 | $5.41M | Insider |
| Robert J. Palmisano | 19.44% | 2,301,021 | $1.89M | Insider |
| Strathspey Crown Holdings Group LLC | 17.16% | 2,031,773 | $1.67M | Insider |
| Dauntless Investment Group LLC | 9.50% | 1,125,000 | $924.75k | Institution |
| Marc Forth | 6.34% | 750,547 | $616.95k | Insider |
| Barclays PLC | 5.94% | 702,645 | $577.57k | Insider |
| Chad Oh | 2.47% | 292,545 | $240.47k | Insider |
| Jost Fischer | 2.25% | 266,785 | $219.30k | Insider |
| Alexander Blair Wilson | 2.21% | 261,538 | $214.98k | Insider |
AEON vs Biotech Stocks
Aeon Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.